CME Group Inc. (NASDAQ:CME) Shares Sold by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC trimmed its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 24.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,264 shares of the financial services provider's stock after selling 2,391 shares during the quarter. Fifth Third Wealth Advisors LLC's holdings in CME Group were worth $1,603,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Caprock Group LLC grew its holdings in shares of CME Group by 10.1% during the third quarter. Caprock Group LLC now owns 6,080 shares of the financial services provider's stock valued at $1,342,000 after buying an additional 559 shares during the last quarter. Aviso Wealth Management grew its holdings in CME Group by 42.7% during the third quarter. Aviso Wealth Management now owns 10,661 shares of the financial services provider's stock valued at $2,352,000 after purchasing an additional 3,191 shares during the period. GLOBALT Investments LLC GA lifted its holdings in CME Group by 2.2% during the third quarter. GLOBALT Investments LLC GA now owns 5,925 shares of the financial services provider's stock valued at $1,307,000 after purchasing an additional 125 shares during the last quarter. Quest Partners LLC boosted its holdings in CME Group by 70.6% in the 3rd quarter. Quest Partners LLC now owns 23,505 shares of the financial services provider's stock worth $5,186,000 after buying an additional 9,724 shares during the period. Finally, Claro Advisors LLC bought a new stake in shares of CME Group during the 3rd quarter valued at $670,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 12.01 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the firm's stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock worth $3,441,063 over the last 90 days. Corporate insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CME shares. Redburn Atlantic lowered CME Group from a "buy" rating to a "neutral" rating and set a $244.00 target price on the stock. in a research note on Tuesday, October 8th. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research note on Monday, October 28th. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a "market perform" rating in a research note on Thursday, July 25th. Oppenheimer raised their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research report on Thursday, October 24th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on CME Group from $227.00 to $226.00 and set a "hold" rating for the company in a research note on Monday, November 11th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $224.47.

CME Group Trading Down 0.7 %

CME traded down $1.66 on Wednesday, hitting $228.00. The company had a trading volume of 2,113,971 shares, compared to its average volume of 1,913,094. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $82.16 billion, a P/E ratio of 24.15, a PEG ratio of 5.20 and a beta of 0.55. The company's fifty day moving average price is $223.02 and its 200 day moving average price is $210.69. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.74.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm's revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.25 EPS. As a group, equities analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group's dividend payout ratio is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.